Hiroshi Nishino

2.4k total citations
109 papers, 1.7k citations indexed

About

Hiroshi Nishino is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroshi Nishino has authored 109 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 37 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroshi Nishino's work include Head and Neck Cancer Studies (18 papers), Salivary Gland Tumors Diagnosis and Treatment (12 papers) and Head and Neck Surgical Oncology (11 papers). Hiroshi Nishino is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Salivary Gland Tumors Diagnosis and Treatment (12 papers) and Head and Neck Surgical Oncology (11 papers). Hiroshi Nishino collaborates with scholars based in Japan, United States and Russia. Hiroshi Nishino's co-authors include Frank A. Rubino, Joseph E. Parisi, Jerry W. Swanson, Keiichi Ichimura, Takeharu Kanazawa, Mamoru Miyata, Joseph E. Parisi, Kazuhiro Ishikawa, Tsutomu Yamaguchi and Shinichi Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hiroshi Nishino

93 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Nishino Japan 21 599 445 348 345 264 109 1.7k
Massimo Fusconi Italy 24 580 1.0× 511 1.1× 286 0.8× 163 0.5× 133 0.5× 78 1.8k
Menachem Gross Israel 22 298 0.5× 552 1.2× 186 0.5× 294 0.9× 105 0.4× 112 1.7k
Masayuki Shintaku Japan 22 252 0.4× 375 0.8× 215 0.6× 345 1.0× 408 1.5× 155 1.7k
Mary S. Richardson United States 24 335 0.6× 689 1.5× 261 0.8× 151 0.4× 279 1.1× 58 1.7k
Wai‐Kuen Ho Hong Kong 17 209 0.3× 335 0.8× 188 0.5× 240 0.7× 425 1.6× 38 1.3k
David Holzmann Switzerland 30 540 0.9× 1.2k 2.6× 360 1.0× 214 0.6× 404 1.5× 131 2.7k
Roland Giger Switzerland 22 432 0.7× 838 1.9× 188 0.5× 138 0.4× 321 1.2× 110 1.7k
Tuvia Hadar Israel 24 329 0.5× 718 1.6× 220 0.6× 125 0.4× 345 1.3× 81 1.6k
P. Dessi France 24 245 0.4× 1.0k 2.3× 188 0.5× 250 0.7× 206 0.8× 117 1.7k
Jenq‐Yuh Ko Taiwan 30 765 1.3× 1.1k 2.5× 385 1.1× 450 1.3× 844 3.2× 120 2.7k

Countries citing papers authored by Hiroshi Nishino

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Nishino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Nishino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Nishino more than expected).

Fields of papers citing papers by Hiroshi Nishino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Nishino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Nishino. The network helps show where Hiroshi Nishino may publish in the future.

Co-authorship network of co-authors of Hiroshi Nishino

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Nishino. A scholar is included among the top collaborators of Hiroshi Nishino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Nishino. Hiroshi Nishino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Igarashi, Takeshi, Hiroki Goto, Tōru Sasaki, et al.. (2024). Clinical course and vascular endothelial growth factor signaling system expression in maxillary angiosarcoma: A case report. Science Progress. 107(3). 342244518–342244518.
3.
Hasegawa, Masayo, Yusuke Amano, Daisuke Matsubara, et al.. (2024). Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis. Cancer Medicine. 13(13). e7431–e7431. 6 indexed citations
4.
Shinozaki, Takeshi, M. Ebihara, Satoru Iwase, et al.. (2016). Quality of life and functional status of terminally ill head and neck cancer patients: a nation-wide, prospective observational study at tertiary cancer centers in Japan. Japanese Journal of Clinical Oncology. 47(1). 47–53. 10 indexed citations
5.
Noguchi, Tadahide, Kenichi Sasaguri, Shigeru Ono, et al.. (2016). Surgical Management of Duplication of the Pituitary Gland-Plus Syndrome With Epignathus, Cleft Palate, Duplication of Mandible, and Lobulated Tongue. Journal of Craniofacial Surgery. 28(2). e141–e144. 2 indexed citations
6.
Nishino, Hiroshi. (2015). Treatment of Maxillary Sinus Carcinoma. Practica Oto-Rhino-Laryngologica. 108(3). 163–173.
7.
Nishino, Hiroshi, et al.. (2013). The Intraparotid Facial Nerve Schwanoma. Practica Oto-Rhino-Laryngologica. 106(10). 872–873. 1 indexed citations
8.
Nishino, Hiroshi, et al.. (2010). Partial maxillectomy. Toukeibu Gan. 36(4). 379–382.
9.
Ishikawa, Kazuhiro, Hideshi Ishii, Hiroshi Nishino, Yusuke Furukawa, & Keiichi Ichimura. (2006). THE ROLE OF RAD9 IN HEAD AND NECK CANCER. Toukeibu Gan. 32(4). 417–422.
10.
Nishino, Hiroshi, et al.. (2004). RESULTS OF MULTI-MODALITY THERAPY with SURGERY, RADIOTHERAPY, AND REGIONAL CHEMOTHERAPY FOR MALIGNANT MAXILLARY SINUS TUMORS. Toukeibu Gan. 30(4). 539–544. 1 indexed citations
12.
Nishino, Hiroshi, et al.. (2003). Vital Prognosis of Diabetic Foot Gangrene : A Clinical and Statistical Study of 140 Cases. 113(2). 135–144. 1 indexed citations
13.
Ahlskog, J. Eric, Hiroshi Nishino, Virgilio Gerald H. Evidente, et al.. (2001). Persistent chorea triggered by hyperglycemic crisis in diabetics. Movement Disorders. 16(5). 890–898. 72 indexed citations
14.
Kanazawa, Takeharu, Hiroshi Nishino, & Keiichi Ichimura. (2000). Pleomorphic adenoma of the pterygopalatine fossa: a case report. European Archives of Oto-Rhino-Laryngology. 257(8). 433–435. 6 indexed citations
15.
Nishino, Hiroshi, Kazuhiro Ishikawa, Takeharu Kanazawa, et al.. (1999). Surgical Treatment for Squamous Cell Carcinoma of the Lateral Wall of the Oropharynx; A Transoral Approach.. Practica Oto-Rhino-Laryngologica. 92(6). 651–656. 1 indexed citations
16.
Tanaka, Hiromu, Hiroshi Nishino, Tetsuji Sawada, et al.. (1987). Biliary penetration of cefbuperazone in the presence and absence of obstructive jaundice. Journal of Antimicrobial Chemotherapy. 20(3). 417–420. 2 indexed citations
17.
Sowa, Michio, et al.. (1980). EXOGASTRIC DEVELOPING TYPE CARCINOMA OF THE STOMACH. The Japanese Journal of Gastroenterological Surgery. 13(7). 880–885.
19.
Morita, Seiji, et al.. (1977). Metabolic fate of carteolol hydrochloride (OPC-1085), a new β-adrenergic blocking agent. VI. Pharmacokinetics of carteolol in rat, dog, rabbit and man. Folia Pharmacologica Japonica. 73(2). 229–235. 4 indexed citations
20.
Kohri, Hideaki, Seiji Morita, KAZUYUKI NAKAGAWA, & Hiroshi Nishino. (1976). Metabolic fate of carteolol hydrochloride (OPC-1085), a new β-adrenergic blocking agent. III. Autoradiographic distribution studies in mice.. Folia Pharmacologica Japonica. 72(3). 341–350. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026